0001213900-18-008697.txt : 20180703 0001213900-18-008697.hdr.sgml : 20180703 20180703160729 ACCESSION NUMBER: 0001213900-18-008697 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180628 FILED AS OF DATE: 20180703 DATE AS OF CHANGE: 20180703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Liu Lei CENTRAL INDEX KEY: 0001472651 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34711 FILM NUMBER: 18937156 MAIL ADDRESS: STREET 1: ROOM 507-513, 5TH FLOOR,A BUILDING STREET 2: MEIDU PLAZA, GONGSHU DISTRICT CITY: HANGZHOU STATE: F4 ZIP: 310011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHINA JO-JO DRUGSTORES, INC. CENTRAL INDEX KEY: 0001413263 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 980557582 FISCAL YEAR END: 0730 BUSINESS ADDRESS: STREET 1: HAI WAI HAI TONGXIN MANSION FLOOR 6 STREET 2: GONG SHU DISTRICT, HANGZHOU CITY: ZHEJIANG PROVINCE STATE: F4 ZIP: 310008 BUSINESS PHONE: (86) 1501-158-6601 MAIL ADDRESS: STREET 1: HAI WAI HAI TONGXIN MANSION FLOOR 6 STREET 2: GONG SHU DISTRICT, HANGZHOU CITY: ZHEJIANG PROVINCE STATE: F4 ZIP: 310008 FORMER COMPANY: FORMER CONFORMED NAME: KERRISDALE MINING CORP DATE OF NAME CHANGE: 20070924 4 1 ownership.xml OWNERSHIP DOCUMENT X0306 4 2018-06-28 0 0001413263 CHINA JO-JO DRUGSTORES, INC. CJJD 0001472651 Liu Lei HAI WAI HAI TONGXIN MANSION FLOOR 6, GONG SHU DISTRICT HANGZHOU CITY F4 310008 CHINA 1 1 1 0 CEO, Chairman of the Board Common Stock 2018-06-28 4 J 0 225000 0 D 8825482 D Represents 225,000 shares of common stock cancelled by the compensation committee so that it fits within the 675,000 share limitation in Section 1.3.2 of the China Jo-Jo Drugstores, Inc. 2010 Equity Incentive Plan (the "Plan"). The number of securities reported under Item 5 of Table I includes, but not limited to 6,030,000 shares held by Super Marvel Limited, of which the Reporting Person is the executive director and a shareholder, and as such, is deemed to have or share voting and investment controls over such shares. The Tax Cuts and Jobs Act of 2017 removed the 162(m) qualified performance based compensation exemption to the $1 million cap on deductions for compensation to covered executives. Section 1.3.2 was in the Plan to permit grants under the Plan to fit within that exemption. As that exemption no longer applies for grants made in 2018 or thereafter, the Plan has been amended to remove the provisions intended to comply with that exemption, including the one in Section 1.3.2. of the Plan. /s/ Lei Liu 2018-07-03